Research Grant[Cite as http://purl.org/au-research/grants/nhmrc/1027560]
Researchers: Prof Timothy Hughes (Principal investigator) , Prof Deborah White , Prof John Rasko
Brief description Chronic myeloid leukaemia has become a highly treatable condition since targeted therapy became available. There are now 3 highly effective drugs available, imatinib, nilotinib and dasatinib. We are developing drug sensitivity assays that can be used to predict response to these 3 drugs. We propose that these assays could be used to individualise therapy to ensure that the optimal drug can be provided for each patient from diagnosis to provide a cost-effective customized approach to therapy.
Funding Amount $AUD 527,761.87
Funding Scheme Project Grants
Notes Standard Project Grant
- PURL : http://purl.org/au-research/grants/nhmrc/1027560
- nhmrc : 1027560